Further, we found that gene expression of the enzymes that generate ceramide (GBA in the salvage pathway, SMPD in the sphingomyelin pathway, DES1 in the de novo pathway, and ceramide synthases in the catabolic pathway) were significantly increased in breast cancer. This evidence concerns the gene TLCD3B and breast carcinoma.